retifanlimab,pembrolizumab,Bria-IMT
Incyte,Merck,BriaCell Therapeutics
['bria-imt']
$bctx, is presenting positive clinical data from its lead product candidate, bria-imt , summarized in four poster sessions during the 2023 american association for cancer research (aacr)
Slapping dat ask and taking profits is a must. Most importantly, have fun doing it!  Not Financial advice. Don't/never follow my trades. Just watch shite go up!